CDK-TCIP2
Product Specifications
Target
Bcl-6, CDK
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.
Smiles
C(F)(F)(F)C1=C2C(CN(C[C@H]3C[C@@H](C(F)(F)F)CCC3)C2=O)=NC(N)=N1
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2415750 100 µL
Ig kappa chain C region Rabbit Polyclonal Antibody (BF555)
Sign In for Pricing
View Details MBS1295655-01 0.02 mg (E-Coli)
Recombinant Halobacterium salinarum Cell division control protein 6 homolog 5 (cdc6-5)
Sign In for Pricing
View Details MBS1295655-02 0.02 mg (Yeast)
Recombinant Halobacterium salinarum Cell division control protein 6 homolog 5 (cdc6-5)
Sign In for Pricing
View Details MBS1295655-03 0.1 mg (E-Coli)
Recombinant Halobacterium salinarum Cell division control protein 6 homolog 5 (cdc6-5)
Sign In for Pricing
View Details